Palvella Therapeutics, Inc. (PVLA) Revenue History
Annual and quarterly revenue from 2020 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
PVLA Revenue Growth
PVLA Revenue Analysis (2020–2025)
As of May 8, 2026, Palvella Therapeutics, Inc. (PVLA) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q1 2026) recorded $0 in revenue.
Looking at the longer-term picture, PVLA's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $31.4 million in 2021.
When compared to Healthcare sector peers including NKTR (-43.9% YoY), and ARDX (+18.2% YoY). Compare PVLA vs NKTR →
PVLA Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| PVLACurrent | $0 | - | - | - | |
 NKTR | $55M | -43.9% | -18.4% | -236.8% | |
 ARDX | $407M | +18.2% | +121.9% | -10.1% |
PVLA Historical Revenue Data (2020–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $-38,602,000 | - |
| 2024 | $0 | - | $0 | - | $-14,095,000 | - |
| 2023 | $0 | -100.0% | $0 | - | $-11,869,000 | - |
| 2022 | $25.9M | -17.6% | $23.1M | 89.3% | $-43,474,000 | -167.8% |
| 2021 | $31.4M | - | $29.1M | 92.5% | $-51,831,000 | -165.0% |
| 2020 | $29.3M | - | $29.3M | 100.0% | $-33,921,000 | -115.7% |
See PVLA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PVLA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PVLA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPVLA — Frequently Asked Questions
Quick answers to the most common questions about buying PVLA stock.
Is PVLA's revenue growth accelerating or slowing?
PVLA TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is PVLA's long-term revenue growth rate?
Palvella Therapeutics, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is PVLA's revenue distributed by segment?
PVLA reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2020-2025 are available for download. Segment mix reveals concentration and diversification trends.